Bryn Mawr Trust CO Viatris Inc Transaction History

Bryn Mawr Trust CO

$5.25 Billion
Q1 2025

A detailed history of Bryn Mawr Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 13,024 shares of VTRS stock, worth $110,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,024

Previous 17,076 23.73%

Holding current value

$110,183

Previous $212,000 46.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$8.68 - $12.42 $35,171 - $50,325	-4,052 Reduced 23.73%	13,024 $113,000
Q4 2024 Jan 28, 2025	SELL	$11.32 - $13.37 $119,290 - $140,893	-10,538 Reduced 38.16%	17,076 $212,000
Q3 2024 Nov 25, 2024	BUY	$10.32 - $12.13 $284,976 - $334,957	27,614 New	27,614 $320,000
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $4,368 - $5,791	-501 Reduced 4.3%	11,163 $125,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $5,834 - $7,657	-688 Reduced 5.57%	11,664 $100,000
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $11,681 - $14,404	-1,174 Reduced 8.68%	12,352 $129,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $7,465 - $11,719	-761 Reduced 5.33%	13,526 $147,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $1,221 - $1,482	-101 Reduced 0.7%	14,287 $194,000
Q3 2021 Oct 26, 2021	SELL	$13.25 - $15.13 $31,535 - $36,009	-2,380 Reduced 14.19%	14,388 $195,000
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $22,464 - $27,971	-1,732 Reduced 9.36%	16,768 $240,000
Q1 2021 Apr 23, 2021	SELL	$13.59 - $18.54 $79,800 - $108,866	-5,872 Reduced 24.09%	18,500 $259,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $348,519 - $456,731	24,372 New	24,372 $457,000

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

953M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.3B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Viatris Inc Transaction History